FDA Approves Psychedelic Magic Mushrooms Ingredient Psilocybin for Depression Trial Newsweek
The Food and Drug Administration has approved the use of the psychedelic ingredient in magic mushrooms for a drug trial for treatment-resistant depression.
Category: Mushrooms
Magic mushrooms might treat depression? Peter Thiel-backed Compass gets FDA OK to launch Phase IIb trials Endpoints News
For years now, psychedelic scientists have been telling us that tripping on magic mushrooms might “reboot” the brain, clearing out negative thought networks …
New research examines how psychological insights from ‘magic mushrooms’ may help people stop smoking PsyPost
New qualitative research sheds light on how psychedelic-assisted treatment can help defeat tobacco addiction. The study, published in the Journal of …